All In MedTech

Device Trial Radar · NCT07608549

FLASH Pilot Phase 1 Safety Study

A Pilot Study to Determine the Feasibility of Electron FLASH Radiotherapy for Treatment of De-novo Cutaneous Lymphoma

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

10

Planned (sponsor's estimate)

Start

Oct 31, 2029

Primary completion

Dec 31, 2030

Study completion Dec 31, 2031

Sponsor

Lead sponsor
Lesley A. JarvisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Dartmouth College
First posted
May 27, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Device feasibility
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this research trial is to study the safety of electron FLASH treatment for cutaneous lymphoma lesions. In addition, investigators will confirm the accuracy of dose and dose rate delivery of electron FLASH therapy using on-patient dosimetry measurements. Researchers will also determine the response rates of cutaneous lymphomas treated with a low radiation dose in a single fraction using electron UHDR treatments, followed by an assessment of radiation related skin toxicity.

Conditions

  • Cutaneous Lymphoma

Interventions

  • IntraOp Mobetron UHDRDevice

    The Mobetron UDHR System provides electrons for precision radiotherapy of lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated. The FLASH enabled Mobetron System is intended to deliver electron FLASH radiotherapy to participants with cutaneous lymphoma lesions located in extremities.

  • LinacRadiation

    Conventional radiotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidences and grades of all grade-3-or-higher skin toxicities (according to CTCAE version 6.0) that are attributed to the electron FLASH treatment procedure [FLASH treatment safety and toxicity profile].Time frame: 5 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.